BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36329159)

  • 21. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
    Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
    J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can circulating cell free DNA be a promising marker in ovarian cancer? - a genome-scale profiling study in a single institution.
    Zhou H; Zhang X; Liu Q; Yang J; Bai J; Yin M; Cao D; Zhang Q; Zheng L
    J Ovarian Res; 2023 Jan; 16(1):11. PubMed ID: 36641505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
    Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
    Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B; Pu K; Ge L; Wu X
    Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism.
    Bahado-Singh RO; Vishweswaraiah S; Turkoglu O; Graham SF; Radhakrishna U
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial intelligence performance in image-based ovarian cancer identification: A systematic review and meta-analysis.
    Xu HL; Gong TT; Liu FH; Chen HY; Xiao Q; Hou Y; Huang Y; Sun HZ; Shi Y; Gao S; Lou Y; Chang Q; Zhao YH; Gao QL; Wu QJ
    EClinicalMedicine; 2022 Nov; 53():101662. PubMed ID: 36147628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.
    Zhu S; Bao H; Zhang MC; Liu H; Wang Y; Lin C; Zhao X; Liu SL
    BMC Cancer; 2022 Jun; 22(1):662. PubMed ID: 35710397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation signatures and coagulation factors in the peripheral blood leucocytes of epithelial ovarian cancer.
    Li L; Zheng H; Huang Y; Huang C; Zhang S; Tian J; Li P; Sood AK; Zhang W; Chen K
    Carcinogenesis; 2017 Aug; 38(8):797-805. PubMed ID: 28637314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effectiveness of Artificial Intelligence in Detection of Oral Cancer.
    Al-Rawi N; Sultan A; Rajai B; Shuaeeb H; Alnajjar M; Alketbi M; Mohammad Y; Shetty SR; Mashrah MA
    Int Dent J; 2022 Aug; 72(4):436-447. PubMed ID: 35581039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
    Kalachand RD; Stordal B; Madden S; Chandler B; Cunningham J; Goode EL; Ruscito I; Braicu EI; Sehouli J; Ignatov A; Yu H; Katsaros D; Mills GB; Lu KH; Carey MS; Timms KM; Kupryjanczyk J; Rzepecka IK; Podgorska A; McAlpine JN; Swisher EM; Bernards SS; O'Riain C; O'Toole S; O'Leary JJ; Bowtell DD; Thomas DM; Prieske K; Joosse SA; Woelber L; Chaudhry P; Häfner N; Runnebaum IB; Hennessy BT
    J Natl Cancer Inst; 2020 Dec; 112(12):1190-1203. PubMed ID: 32413141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement.
    Faaborg L; Fredslund Andersen R; Waldstrøm M; Høgdall E; Høgdall C; Adimi P; Jakobsen A; Dahl Steffensen K
    Clin Chim Acta; 2021 Nov; 522():152-157. PubMed ID: 34419462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
    J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA Methylation in Ovarian Tumors-a Comparison Between Fresh Tissue and FFPE Samples.
    Oliveira DVNP; Hentze J; O'Rourke CJ; Andersen JB; Høgdall C; Høgdall EV
    Reprod Sci; 2021 Nov; 28(11):3212-3218. PubMed ID: 33891290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental DNA methylation changes and the early prediction of autism in full-term newborns.
    Bahado-Singh RO; Vishweswaraiah S; Aydas B; Radhakrishna U
    PLoS One; 2021; 16(7):e0253340. PubMed ID: 34260616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New-onset postpartum preeclampsia: epigenetic mechanism and prediction.
    Kim SK; Vishweswaraiah S; Macknis J; Yilmaz A; Lalwani A; Mishra NK; Guda C; Ogunyemi D; Radhakrishna U; Bahado-Singh RO
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7179-7187. PubMed ID: 34374309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers.
    Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A
    Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.